Global Herpes Labialis Drugs Market Size, Status and Forecast 2022
- QYR2148047
- 104 Pages
- October 2017
- Medical Devices
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Herpes Labialis Drugs can be split into
Valacyclovir
Aciclovir
Famciclovir
Docosanol
Other
Market segment by Application, Herpes Labialis Drugs can be split into
External Use
Oral
Injection
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Herpes Labialis Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Herpes Labialis Drugs
1.1 Herpes Labialis Drugs Market Overview
1.1.1 Herpes Labialis Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Herpes Labialis Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Herpes Labialis Drugs Market by Type
1.3.1 Valacyclovir
1.3.2 Aciclovir
1.3.3 Famciclovir
1.3.4 Docosanol
1.3.5 Other
1.4 Herpes Labialis Drugs Market by End Users/Application
1.4.1 External Use
1.4.2 Oral
1.4.3 Injection
2 Global Herpes Labialis Drugs Competition Analysis by Players
2.1 Herpes Labialis Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 GSK
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Novartis
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Teva
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Mylan
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Cadila
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Apotex
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Daewoong Pharmaceutical
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Livzon
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Luoxin
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Med shine
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Bayer (Campho Phenique)
3.12 Blistex
3.13 Kelun Group
3.14 Hikma
3.15 Haiwang
3.16 Carmex
3.17 Cipher
4 Global Herpes Labialis Drugs Market Size by Type and Application (2012-2017)
4.1 Global Herpes Labialis Drugs Market Size by Type (2012-2017)
4.2 Global Herpes Labialis Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Herpes Labialis Drugs in Future
4.4 Top Consumer/End Users of Herpes Labialis Drugs
5 United States Herpes Labialis Drugs Development Status and Outlook
5.1 United States Herpes Labialis Drugs Market Size (2012-2017)
5.2 United States Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU Herpes Labialis Drugs Development Status and Outlook
6.1 EU Herpes Labialis Drugs Market Size (2012-2017)
6.2 EU Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)
7 Japan Herpes Labialis Drugs Development Status and Outlook
7.1 Japan Herpes Labialis Drugs Market Size (2012-2017)
7.2 Japan Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)
8 China Herpes Labialis Drugs Development Status and Outlook
8.1 China Herpes Labialis Drugs Market Size (2012-2017)
8.2 China Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)
9 India Herpes Labialis Drugs Development Status and Outlook
9.1 India Herpes Labialis Drugs Market Size (2012-2017)
9.2 India Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Herpes Labialis Drugs Development Status and Outlook
10.1 Southeast Asia Herpes Labialis Drugs Market Size (2012-2017)
10.2 Southeast Asia Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Herpes Labialis Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Herpes Labialis Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Herpes Labialis Drugs Market Size by Application (2017-2022)
12 Herpes Labialis Drugs Market Dynamics
12.1 Herpes Labialis Drugs Market Opportunities
12.2 Herpes Labialis Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Herpes Labialis Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Herpes Labialis Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Figure Herpes Labialis Drugs Product Scope
Figure Global Herpes Labialis Drugs Market Size (Million USD) (2012-2017)
Table Global Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Herpes Labialis Drugs Market Share by Regions in 2016
Figure United States Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Herpes Labialis Drugs Market Share by Type in 2016
Figure Valacyclovir Market Size (Million USD) and Growth Rate (2012-2017)
Figure Aciclovir Market Size (Million USD) and Growth Rate (2012-2017)
Figure Famciclovir Market Size (Million USD) and Growth Rate (2012-2017)
Figure Docosanol Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Herpes Labialis Drugs Market Share by Application in 2016
Table Key Downstream Customer in External Use
Figure Herpes Labialis Drugs Market Size (Million USD) and Growth Rate in External Use (2012-2017)
Table Key Downstream Customer in Oral
Figure Herpes Labialis Drugs Market Size (Million USD) and Growth Rate in Oral (2012-2017)
Table Key Downstream Customer in Injection
Figure Herpes Labialis Drugs Market Size (Million USD) and Growth Rate in Injection (2012-2017)
Table Herpes Labialis Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Herpes Labialis Drugs Market Size Share by Players in 2016
Figure Herpes Labialis Drugs Market Size Share by Players in 2017
Table GSK Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of GSK (2012-2017)
Figure GSK Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Teva Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Teva (2012-2017)
Figure Teva Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Mylan Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Mylan (2012-2017)
Figure Mylan Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Cadila Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Cadila (2012-2017)
Figure Cadila Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Apotex Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Apotex (2012-2017)
Figure Apotex Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Daewoong Pharmaceutical Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Daewoong Pharmaceutical (2012-2017)
Figure Daewoong Pharmaceutical Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Livzon Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Livzon (2012-2017)
Figure Livzon Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Luoxin Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Luoxin (2012-2017)
Figure Luoxin Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Med shine Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Med shine (2012-2017)
Figure Med shine Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Bayer (Campho Phenique) Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Bayer (Campho Phenique) (2012-2017)
Figure Bayer (Campho Phenique) Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Blistex Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Blistex (2012-2017)
Figure Blistex Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Kelun Group Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Kelun Group (2012-2017)
Figure Kelun Group Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Hikma Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Hikma (2012-2017)
Figure Hikma Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Haiwang Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Haiwang (2012-2017)
Figure Haiwang Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Carmex Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Carmex (2012-2017)
Figure Carmex Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Cipher Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Cipher (2012-2017)
Figure Cipher Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Global Herpes Labialis Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2012
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2013
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2014
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2015
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2016
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2017
Table Global Herpes Labialis Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2012
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2013
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2014
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2015
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2016
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Herpes Labialis Drugs
Figure United States Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Herpes Labialis Drugs Market Size Share by Players in 2016
Figure United States Herpes Labialis Drugs Market Size Share by Players in 2017
Figure EU Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Herpes Labialis Drugs Market Size Share by Players in 2016
Figure EU Herpes Labialis Drugs Market Size Share by Players in 2017
Figure Japan Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Herpes Labialis Drugs Market Size Share by Players in 2016
Figure Japan Herpes Labialis Drugs Market Size Share by Players in 2017
Figure China Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Herpes Labialis Drugs Market Size Share by Players in 2016
Figure China Herpes Labialis Drugs Market Size Share by Players in 2017
Figure India Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Herpes Labialis Drugs Market Size Share by Players in 2016
Figure India Herpes Labialis Drugs Market Size Share by Players in 2017
Figure Southeast Asia Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Herpes Labialis Drugs Market Size Share by Players in 2016
Figure Southeast Asia Herpes Labialis Drugs Market Size Share by Players in 2017
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Herpes Labialis Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Herpes Labialis Drugs Market Size Share by Regions in 2017
Figure Global Herpes Labialis Drugs Market Size Share by Regions in 2022
Figure United States Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Herpes Labialis Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2017
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2022
Table Global Herpes Labialis Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2017
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2022
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
